Allogenica
Company Details
Status: Private
Employees: 1-10
Location:
Lyon, France
Type:
sample
Technology:
sample
sample
sample
About: At Allogenica, we are transforming cell therapies for a healthier tomorrow.
Our mission is to ๐ฑ๐ถ๐๐ฟ๐๐ฝ๐ ๐๐ต๐ฒ ๐๐ฟ๐ฒ๐ฎ๐๐บ๐ฒ๐ป๐ ๐น๐ฎ๐ป๐ฑ๐๐ฐ๐ฎ๐ฝ๐ฒ ๐ณ๐ผ๐ฟ ๐ฐ๐ฎ๐ป๐ฐ๐ฒ๐ฟ, ๐ฟ๐ฎ๐ฟ๐ฒ ๐ฑ๐ถ๐๐ฒ๐ฎ๐๐ฒ๐, ๐ฎ๐ป๐ฑ ๐ฎ๐๐๐ผ๐ถ๐บ๐บ๐๐ป๐ฒ ๐ฑ๐ถ๐๐ผ๐ฟ๐ฑ๐ฒ๐ฟ๐.
We're developing a breakthrough cell therapy platform with the potential to:
โข ๐ฅ๐ฒ๐ฝ๐น๐ฎ๐ฐ๐ฒ ๐๐ฟ๐ฎ๐ป๐๐ฝ๐น๐ฎ๐ป๐๐: Providing less invasive, accessible alternatives for thousands of patients who currently have limited treatment options.
โข ๐๐
๐ฝ๐ฎ๐ป๐ฑ ๐ฎ๐ฐ๐ฐ๐ฒ๐๐ ๐ณ๐ผ๐ฟ ๐ฎ๐น๐น: With predictable safety and efficacy, we aim to make cell therapies available to a a broader patient population.
โข ๐๐ฟ๐ฎ๐บ๐ฎ๐๐ถ๐ฐ๐ฎ๐น๐น๐ ๐ฟ๐ฒ๐ฑ๐๐ฐ๐ฒ ๐ฐ๐ผ๐๐๐: By streamlining production, we aim to significantly lower the cost of cell therapies, making transformative treatments more accessible globally.
๐๐๐๐๐ข๐ง๐ ๐๐๐ฅ๐ฅ ๐๐ก๐๐ซ๐๐ฉ๐ฒ ๐๐๐ฏ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง
Founded in 2022, Allogenica has rapidly emerged as a pioneer in the field. Our innovative approach includes:
โข ๐ฃ๐ฟ๐ผ๐ฝ๐ฟ๐ถ๐ฒ๐๐ฎ๐ฟ๐ ๐ฃ๐ฟ๐ฒ-๐ง ๐๐ฒ๐น๐น ๐ง๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ถ๐ฒ๐: Enhancing compatibility with patients' immune systems, reducing the risk of rejection.
โข ๐ฆ๐ฐ๐ฎ๐น๐ฎ๐ฏ๐น๐ฒ, ๐๐ฟ๐ผ๐ฎ๐ฑ ๐๐ฝ๐ฝ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป๐: Our platform has the potential to treat a diverse range of diseases, ensuring scalability and reaching more patients in need.
โข ๐๐ผ๐๐-๐๐ณ๐ณ๐ฒ๐ฐ๐๐ถ๐๐ฒ, ๐ฅ๐ฎ๐ฝ๐ถ๐ฑ ๐ฆ๐ผ๐น๐๐๐ถ๐ผ๐ป๐: Delivering affordable and faster-to-market therapies, to change lives on a global scale, potentially impacting millions.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Allogenica | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.